Structure Therapeutics Inc.

GPCR

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001698149-26-000002
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Stevens Raymond C (CEO)

Summary

Type

Sell

Net shares

-53,454

% of shares

-1.94%

Amount (USD)

$1,121,999

Insider confidence score

17.5 out of 100

Negative

  • Large discretionary sell (≥1% of shares)
  • Very large sell amount ($1M+)

Stock transactions

Transaction 1

Security

Ordinary Shares

Action

Tax_withhold

Date

2026-03-03

Code

F

Net shares

-53,454.0

Price per Share

$20.99

Amount (USD)

$1,121,999.46

Acquired/Disposed

Disposed

Shares Owned Before

1,194,830.0

Shares Owned After

1,141,376.0

Derivative Transactions

Transaction 1

Security

American Depositary Shares

Action

Grant

Date

2025-11-20

Code

A

Net shares

+824.0

Acquired/Disposed

Acquired

Shares Owned Before

1,000.0

Shares Owned After

1,824.0

Filing's footnotes

1. The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.

2. Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.

3. By Raymond Stevens and Vivian Urena-Stevens, as Co-Trustees of the Stevens 2001 Revocable Trust, dated March 28, 2001.

4. Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.

5. Voluntary reporting of the acquisition of 824 ADSs by the Reporting Person on November 20, 2025 pursuant to the Issuer's Employee Share Purchase Plan.

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.